Infectious Risks With Immunosuppressive Therapy Used to Treat Common Neuro-Ophthalmic Disorders

Update Item Information
Identifier 20210221_nanos_infectious1_02-slides
Title Infectious Risks With Immunosuppressive Therapy Used to Treat Common Neuro-Ophthalmic Disorders
Creator Lindsey De Lott, MD, MS
Subject Corticosteroids; Immunosuppressive Therapies; Immunotherapy; Immunomudulating Drugs; Infection
Description Neuro-ophthalmology has seen a rapid rise in the use of targeted and untargeted immunotherapies as the mechanisms underlying immune-mediated neuro-ophthalmic disorders are elucidated. Neuro-ophthalmologists can take an active role in ensuring that appropriate infection pre-screening and infection prevention steps are not overlooked, even if they are not the primary prescriber of these medications.
Date 2021-02
Language eng
Format application/pdf
Type Text
Source 2021 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2021: Infectious Diseases in Neuro-Ophthalmology: It's Not Just COVID-19
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2021. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6ps3trk
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Primary Lindsey De Lott, MD, MS
Setname ehsl_novel_nam
ID 1694025
Reference URL https://collections.lib.utah.edu/ark:/87278/s6ps3trk
Back to Search Results